Literature DB >> 15631882

Prevalence of factor V Leiden and G6PD 1311 silent mutations in Dalmatian population.

Vedrana Cikes1, Irina Abaza, Vjekoslav Krzelj, Ivana Marinović Terzić, Robert Tafra, Anuska Trlaja, Eugenija Marusić, Janos Terzić.   

Abstract

BACKGROUND: Factor V Leiden has been described as a common genetic risk factor for venous thromboembolism. The geographic distribution of this abnormality varies greatly, being high in Europe and almost absent in Asia and Africa. Particularly high prevalence is observed in some Mediterranean countries, which suggests the Mediterranean origin of this mutation. Similarly, prevalence of silent mutation 1311 of the G6PD gene seems to be higher among Mediterranean populations. Since the Dalmatian population (of south Croatia) geographically belongs to the Mediterranean populations we analyzed the prevalence of FV-Leiden and silent mutation 1311 in this region. Furthermore, because the coincidence of G6PD deficiency and venous thromboembolism was described earlier, we tested a possible association of FV-Leiden and G6PD deficiency.
METHODS: One hundred sixty-eight healthy blood donors and 55 G6PD deficient individuals originating from the Dalmatian region were tested for the presence of FV-Leiden mutation and silent mutation 1311.
RESULTS: Prevalence of FV-Leiden among blood donors was 2.4%, while among G6PD deficient individuals it was significantly higher, 11% (p=0.011). Prevalence of silent mutation 1311 among blood donors and G6PD deficient individuals was 21 and 15%, respectively.
CONCLUSIONS: Observed allele frequencies among individuals originating from the Dalmatian region is similar to the neighboring European and Mediterranean populations. Interestingly, our results indicate the association of the FV-Leiden and G6PD deficiency and warrant further studies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15631882     DOI: 10.1016/j.arcmed.2004.07.005

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  9 in total

1.  Prevalence of 1691G>A FV mutation in Poland compared with that in other Central, Eastern and South-Eastern European countries.

Authors:  Grażyna Adler; Jeremy S C Clark; Beata Loniewska; Ewa Czerska; Nermin N Salkic; Andrzej Ciechanowicz
Journal:  Bosn J Basic Med Sci       Date:  2012-05       Impact factor: 3.363

2.  Thrombophilic gene polymorphism studies in G6PD deficient individuals from Saudi population.

Authors:  Khalid K Alharbi; Imran Ali Khan; Rabbani Syed
Journal:  Bioinformation       Date:  2012-12-19

3.  The glucose-6-phosphate dehydrogenase Mahidol variant protects against uncomplicated Plasmodium vivax infection and reduces disease severity in a Kachin population from northeast Myanmar.

Authors:  Haoan Yi; Hong Li; Luxin Liang; Yanrui Wu; Lu Zhang; Wanfang Qiu; Weiyang Jiang; Fang Yang; Qing Li; Zhaoqing Yang; Chengqi Wang; Liwang Cui; Yongshu He
Journal:  Infect Genet Evol       Date:  2019-07-24       Impact factor: 3.342

4.  Rapid and reliable detection of glucose-6-phosphate dehydrogenase (G6PD) gene mutations in Han Chinese using high-resolution melting analysis.

Authors:  Jing-bin Yan; Hong-ping Xu; Can Xiong; Zhao-rui Ren; Guo-li Tian; Fanyi Zeng; Shu-zhen Huang
Journal:  J Mol Diagn       Date:  2010-03-04       Impact factor: 5.568

5.  High incidence of glucose-6-phosphate dehydrogenase deficiency in Croatian island isolate: example from Vis island, Croatia.

Authors:  Josko Markić; Vjekoslav Krzelj; Anita Markotić; Eugenija Marusić; Luka Stricević; Jaksa Zanchi; Nada Bosnjak; Ada Sapunar
Journal:  Croat Med J       Date:  2006-08       Impact factor: 1.351

6.  The prevalence of factor V Leiden, prothrombin G20210A and methylenetetrahydrofolate reductase polymorphism C677T among G6PD deficient individuals from Western Iran.

Authors:  Hadi Mozafari; Zohreh Rahimi; Azadeh Heidarpour; Mahsa Fallahi; Adraiana Muniz
Journal:  Mol Biol Rep       Date:  2009-02-15       Impact factor: 2.316

7.  Prevalence of positive factor V Leiden and prothrombin mutations in samples tested for thrombophilia in Saudi Arabia.

Authors:  Fatimah Madkhaly; Abdulaziz Alshaikh; Hala Aba Alkhail; Randa Alnounou; Tarek Owaidah
Journal:  Am J Blood Res       Date:  2021-06-15

8.  Epidemiology of activated protein C resistance and factor v leiden mutation in the mediterranean region.

Authors:  Mehrez M Jadaon
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-09-08       Impact factor: 2.576

9.  Influence of the Inherited Glucose-6-phosphate Dehydrogenase Deficiency on the Appearance of Neonatal Hyperbilirubinemia in Southern Croatia.

Authors:  Anet Papazovska Cherepnalkovski; Eugenija Marusic; Katica Piperkova; Bernarda Lozic; Ana Skelin; Todor Gruev; Vjekoslav Krzelj
Journal:  Acta Inform Med       Date:  2015-10-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.